Using Aspirin to Improve Immunological Features of Ovarian Tumors
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant
chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking
surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
Phase:
Early Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Sharp Clinical Services, Inc United States Department of Defense